CLINICAL_TRIALS
trial_result
· 2011-06-10
Clinical Trial Update: Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema [Phase 1]
Summary
A Phase 1 study of VEGF Trap (aflibercept) for diabetic macular edema has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Diabetic Macular Edema | Phase 1 | Status: COMPLETED